Packaging division to participate in the mega-trend of the pharmaceutical industry
– Packaging division: Set for secular long-term growth
– Solid track record
– Sustainability at its core
– Outlook for FY2024
– Valuation and conclusion
Packaging division to participate in the mega-trend of the pharmaceutical industry
– Packaging division: Set for secular long-term growth
– Solid track record
– Sustainability at its core
– Outlook for FY2024
– Valuation and conclusion
Resilient performance and positive outlook after the separation of the Paper division
– Sales and profitability impacted by lower materials cost
– Segmental performance
– Outlook for FY2024
– Valuation and conclusion
Separation of Paper business from Chemistry and Packaging activities
– Deal Overview
– Focus on high growth and superior margin business
– Expanding the Chemical business inorganically in high-growth markets
– Strategic focus and prospects for Perlen Industrieholding AG post-separation
– Mitigate valuation discount and enhance investor value
– CPH Group AG after the transaction
– Valuation and conclusion
CPH Chemie + Papier Holding AG (CPH) announces plan to separate Paper business from Chemistry and Packaging activities
– Deal Overview
– Deal Rationale
– Focus on high growth and superior margin business
– Strategic focus and prospects for Perlen Industrieholding AG post-separation
– Valuation and conclusion
Resilient performance amidst challenges
– Segmental performance
– Outlook for FY2024
– Valuation and conclusion
FY 2023 targets reaffirmed amidst uncertain markets and focus on implementation of sustainability strategy
– Investor Day summary
– Sustainability
– Other highlights
– Valuation and conclusion
Mixed performance amid challenging market
– Profitability remains intact
– Outlook for FY2023e
– Valuation and conclusion
Broad-based growth across all divisions
– Elevated levels of profitability
– Outlook for FY2023
– Valuation and conclusion
Strong volumes and higher realizations lifts CPH’s profitability
– FY2022 guidance raised again with group EBIT guided above CHF 100 million
– Valuation and conclusion
Rising demand for products in the Chemistry division to drive future growth